Investor mix
6 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |
Provider of cancer drugs development services
6 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |